{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:03:55Z","timestamp":1771650235448,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Considering the fact that COVID-19 has undergone various changes over time, its symptoms have also varied. The aim of this study is to describe and compare the changes in personal characteristics, symptoms, and underlying conditions of individuals infected with different strains of COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This descriptive-analytical study was conducted on 46,747 patients who underwent PCR testing during a two-year period from February 22, 2020 to February 23, 2022, in South Khorasan province, Iran. Patient characteristics and symptoms were extracted based on self-report and the information system. The data were analyzed using logistic regression and artificial neural network approaches. The R software was used for analysis and a significance level of 0.05 was considered for the tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 46,747 cases analyzed, 23,239 (49.7%) were male, and the mean age was 51.48\u2009\u00b1\u200921.41 years. There was a significant difference in symptoms among different variants of the disease (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The factors with a significant positive association were myalgia (OR: 2.04; 95% CI, 1.76 \u2013 2.36), cough (OR: 1.93; 95% CI, 1.68\u20142.22), and taste or smell disorder (OR: 2.62; 95% CI, 2.1 \u2013 3.28). Additionally, aging was found to increase the likelihood of testing positive across the six periods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We found that older age, myalgia, cough and taste\/smell disorder are better factors compared to dyspnea or high body temperature, for identifying a COVID-19 patient. As the disease evolved, chills and diarrhea, demonstrated prognostic strength as in Omicron.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08813-9","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T12:03:06Z","timestamp":1701172986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Changes in symptoms and characteristics of COVID-19 patients across different variants: two years study using neural network analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Seyed Hossein","family":"Torabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Ebrahimzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Salmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"8813_CR1","doi-asserted-by":"crossref","unstructured":"Scovino AM, Dahab EC, Vieira GF, Freire-de-Lima L, Freire-de-Lima CG, Morrot A. SARS-CoV-2\u2019s Variants of Concern: A Brief Characterization. Front Immunol. 2022;13:834098.","DOI":"10.3389\/fimmu.2022.834098"},{"issue":"4","key":"8813_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of V","year":"2020","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536\u201344.","journal-title":"Nat Microbiol"},{"key":"8813_CR3","volume-title":"World Health Organisation","author":"WHO","year":"2020","unstructured":"WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it. In: World Health Organisation. 2020."},{"key":"8813_CR4","unstructured":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 2020. https:\/\/www.who.int\/news\/item\/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)."},{"key":"8813_CR5","unstructured":"WHO Director-General's remarks at the Member State Briefing on the report of the international team studying the origins of SARS-CoV-2. 2021.\u00a0https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-remarks-at-the-member-state-briefing-on-the-report-of-the-international-team-studying-the-origins-of-sars-cov-2."},{"key":"8813_CR6","unstructured":"Tracking SARS-CoV-2 variants.\u00a0https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/."},{"key":"8813_CR7","volume-title":"World Health Organization,Coronavirus disease (COVID-19): variants of SARS-COV-2. World Health Organization","author":"WHO","year":"2021","unstructured":"WHO. World Health Organization,Coronavirus disease (COVID-19): variants of SARS-COV-2. World Health Organization. 2021."},{"issue":"4","key":"8813_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.annemergmed.2020.05.022","volume":"76","author":"O Peyrony","year":"2020","unstructured":"Peyrony O, Marbeuf-Gueye C, Truong V, Giroud M, Rivi\u00e8re C, Khenissi K, Legay L, Simonetta M, Elezi A, Principe A. Accuracy of emergency department clinical findings for diagnosis of coronavirus disease 2019. Ann Emerg Med. 2020;76(4):405\u201312.","journal-title":"Ann Emerg Med"},{"issue":"10223","key":"8813_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507\u201313.","journal-title":"The Lancet"},{"key":"8813_CR10","volume-title":"Symptoms of COVID-19","author":"Centers for Disease Control and Prevention","year":"2022","unstructured":"Prevention TCoDCa. Symptoms of COVID-19. 2022."},{"issue":"2","key":"8813_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/qjmed\/hcaa326","volume":"114","author":"CH Hawkes","year":"2020","unstructured":"Hawkes CH. Smell, taste and COVID-19: testing is essential. QJM. 2020;114(2):83\u201391.","journal-title":"QJM."},{"issue":"7","key":"8813_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1473-3099(22)00154-2","volume":"22","author":"P Bager","year":"2022","unstructured":"Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, M\u00f8ller CH, Skov RL, Valentiner-Branth P, Voldstedlund M, Fischer TK, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect Dis. 2022;22(7):967\u201376.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"8813_CR13","doi-asserted-by":"publisher","first-page":"e232328","DOI":"10.1001\/jamanetworkopen.2023.2328","volume":"6","author":"MW Sumner","year":"2023","unstructured":"Sumner MW, Xie J, Zemek R, Winston K, Freire G, Burstein B, Kam A, Emsley J, Gravel J, Porter R. Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada. JAMA Netw Open. 2023;6(3):e232328.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"8813_CR14","doi-asserted-by":"publisher","first-page":"e2155250","DOI":"10.1080\/22221751.2022.2155250","volume":"12","author":"K Miyashita","year":"2023","unstructured":"Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H, Karayama M, Suzuki Y, Fujisawa T, Enomoto N. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Emerg Microbes Infect. 2023;12(1):e2155250.","journal-title":"Emerg Microbes Infect"},{"key":"8813_CR15","doi-asserted-by":"crossref","unstructured":"Schulze H, Bayer W. Changes in symptoms experienced by SARS-Cov-2-infected individuals\u2013from the first wave to the Omicron variant. Front Virol. 2022;2:880707.","DOI":"10.3389\/fviro.2022.880707"},{"key":"8813_CR16","doi-asserted-by":"crossref","unstructured":"Whitaker M, Elliott J, Bodinier B, Barclay W, Ward H, Cooke G, Donnelly CA, Chadeau-Hyam M, Elliott P. Variant-specific symptoms of COVID-19 among 1,542,510 people in England. medRxiv. 2022:2022.05.","DOI":"10.1101\/2022.05.21.22275368"},{"key":"8813_CR17","unstructured":"Roser HRaEMaLR-GaCAaCGaEO-OaJHaBMaDBaM: Coronavirus Pandemic (COVID-19). Our World in Data 2020. https:\/\/ourworldindata.org\/covid-vaccinations?country=SYR."},{"issue":"4","key":"8813_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41592-023-01769-3","volume":"20","author":"K Gangavarapu","year":"2023","unstructured":"Gangavarapu K, Latif AA, Mullen JL, Alkuzweny M, Hufbauer E, Tsueng G, Haag E, Zeller M, Aceves CM, Zaiets K, et al. Outbreak info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nat Methods. 2023;20(4):512\u201322.","journal-title":"Nat Methods"},{"key":"8813_CR19","unstructured":"Centers for Disease Control and Prevention. Screening Clients for COVID-19 at Homeless Shelters or Encampments. 2020."},{"key":"8813_CR20","doi-asserted-by":"crossref","unstructured":"Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied logistic regression, vol. 398. New Jersey: Wiley; 2013.","DOI":"10.1002\/9781118548387"},{"key":"8813_CR21","doi-asserted-by":"publisher","first-page":"100471","DOI":"10.1016\/j.sste.2021.100471","volume":"40","author":"N Kianfar","year":"2022","unstructured":"Kianfar N, Mesgari MS, Mollalo A, Kaveh M. Spatio-temporal modeling of COVID-19 prevalence and mortality using artificial neural network algorithms. Spatial Spatio-temporal Epidemiol. 2022;40:100471.","journal-title":"Spatial Spatio-temporal Epidemiol"},{"issue":"4","key":"8813_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF02551274","volume":"2","author":"G Cybenko","year":"1989","unstructured":"Cybenko G. Approximation by superpositions of a sigmoidal function. Math Control Signals Systems. 1989;2(4):303\u201314.","journal-title":"Math Control Signals Systems"},{"key":"8813_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9890-3","volume-title":"Data mining with Rattle and R: The art of excavating data for knowledge discovery","author":"G Williams","year":"2011","unstructured":"Williams G. Data mining with Rattle and R: The art of excavating data for knowledge discovery. New York: Springer Science & Business Media; 2011."},{"issue":"1","key":"8813_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-022-07312-7","volume":"22","author":"E Hesni","year":"2022","unstructured":"Hesni E, Sayad B, Khosravi Shadmani F, Najafi F, Khodarahmi R, Rahimi Z, Bozorgomid A, Sayad N. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study. BMC Infect Dis. 2022;22(1):1\u201312.","journal-title":"BMC Infect Dis"},{"key":"8813_CR25","doi-asserted-by":"crossref","unstructured":"Mousavi SF, Ebrahimi M, Moghaddam SA, Moafi N, Jafari M, Tavakolian A, Heidary M. Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study. Vacunas. 2022;24(1):27\u201336.","DOI":"10.1016\/j.vacun.2022.08.002"},{"issue":"1","key":"8813_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-022-02398-x","volume":"20","author":"A Godbout","year":"2022","unstructured":"Godbout A, Drolet M, Mondor M, Simard M, Sauvageau C, De Serres G, Brisson M. Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic. BMC Med. 2022;20(1):1\u201314.","journal-title":"BMC Med"},{"issue":"1","key":"8813_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-09037-8","volume":"12","author":"J Wambua","year":"2022","unstructured":"Wambua J, Hermans L, Coletti P, Verelst F, Willem L, Jarvis CI, Gimma A, Wong KL, Lajot A, Demarest S. The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic. Sci Rep. 2022;12(1):1\u201312.","journal-title":"Sci Rep"},{"key":"8813_CR28","doi-asserted-by":"crossref","unstructured":"Roland LT, Gurrola JG, Loftus PA, Cheung SW, Chang JL. Smell and taste symptom\u2010based predictive model for COVID\u201019 diagnosis. Int Forum Allergy Rhinol. 2020.10(7):832\u20138.","DOI":"10.1002\/alr.22602"},{"key":"8813_CR29","doi-asserted-by":"publisher","first-page":"106832","DOI":"10.1016\/j.rmed.2022.106832","volume":"197","author":"VP Guntur","year":"2022","unstructured":"Guntur VP, Modena BD, Manka LA, Eddy JJ, Liao S-Y, Goldstein NM, Zelarney P, Horn CA, Keith RC, Make BJ. Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral center. Respir Med. 2022;197:106832.","journal-title":"Respir Med"},{"key":"8813_CR30","doi-asserted-by":"crossref","unstructured":"Sun Y, Koh V, Marimuthu K, Ng OT, Young B, Vasoo S, Chan M, Lee VJ, De PP, Barkham T. Epidemiological and clinical predictors of COVID-19. Clin Infect Dis. 2020;71(15):786\u201392.","DOI":"10.1093\/cid\/ciaa322"},{"issue":"5","key":"8813_CR31","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/ije\/dyaa134","volume":"49","author":"M Chadeau-Hyam","year":"2020","unstructured":"Chadeau-Hyam M, Bodinier B, Elliott J, Whitaker MD, Tzoulaki I, Vermeulen R, Kelly-Irving M, Delpierre C, Elliott P. Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data. Int J Epidemiol. 2020;49(5):1454\u201367.","journal-title":"Int J Epidemiol"},{"key":"8813_CR32","first-page":"CD013665","volume":"2","author":"T Struyf","year":"2021","unstructured":"Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Domen J, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev. 2021;2:CD013665.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"8813_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-021-01532-0","volume":"18","author":"G Sabetian","year":"2021","unstructured":"Sabetian G, Moghadami M. Hashemizadeh Fard Haghighi L, Shahriarirad R, Fallahi MJ, Asmarian N, Moeini YS: COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran. Virol J. 2021;18(1):1\u20138.","journal-title":"Virol J"},{"issue":"3","key":"8813_CR34","first-page":"E304","volume":"61","author":"Y Alimohamadi","year":"2020","unstructured":"Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg. 2020;61(3):E304\u201312.","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"8813_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/s12879-021-06363-6","volume":"21","author":"L Goshayeshi","year":"2021","unstructured":"Goshayeshi L, Akbari Rad M, Bergquist R, Allahyari A, Hashemzadeh K, Milani N, Gholian-Aval M, Rezaeitalab F, Sadeghi Quchani MJ, Nahbandani Z, et al. Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences. Iran BMC Infect Dis. 2021;21(1):656.","journal-title":"Iran BMC Infect Dis"},{"issue":"39","key":"8813_CR36","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.15585\/mmwr.mm6939e1","volume":"69","author":"TK Boehmer","year":"2020","unstructured":"Boehmer TK, DeVies J, Caruso E, van Santen KL, Tang S, Black CL, Hartnett KP, Kite-Powell A, Dietz S, Lozier M. Changing age distribution of the COVID-19 pandemic\u2014United States, May\u2013August 2020. Morb Mortal Wkly Rep. 2020;69(39):1404.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"8813_CR37","doi-asserted-by":"publisher","first-page":"633 e639","DOI":"10.1016\/j.cmi.2020.12.029","volume":"27","author":"AK Feehan","year":"2021","unstructured":"Feehan AK, Fort D, Velasco C, Burton JH, Garcia-Diaz J, Price-Haywood EG, Sapp E, Pevey D, Seoane L. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study. Clin Microbiol Infect. 2021;27(4):633 e639-633 e616.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"8813_CR38","doi-asserted-by":"publisher","first-page":"e00273","DOI":"10.1128\/Spectrum.00273-21","volume":"9","author":"Y Song","year":"2021","unstructured":"Song Y, Ge Z, Cui S, Tian D, Wan G, Zhu S, Wang X, Wang Y, Zhao X, Xiang P. COVID-19 cases from the first local outbreak of the SARS-CoV-2 B. 1.1. 7 variant in China may present more serious clinical features: a prospective, comparative cohort study. Microbiol Spectrum. 2021;9(1):e00273-00221.","journal-title":"Microbiol Spectrum"},{"issue":"2","key":"8813_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/geriatrics5020025","volume":"5","author":"DR Petretto","year":"2020","unstructured":"Petretto DR, Pili R. Ageing and COVID-19: What Is the Role for Elderly People? Geriatrics. 2020;5(2):25.","journal-title":"Geriatrics"},{"key":"8813_CR40","unstructured":"Vaira LA, De Riu G, editors. Reader response: Loss of smell in COVID-19 patients. MRI data reveals a transient edema of the olfactory clefts. 2021."},{"key":"8813_CR41","doi-asserted-by":"crossref","unstructured":"Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):1\u20135.","DOI":"10.1038\/s41368-020-0074-x"},{"issue":"5","key":"8813_CR42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak W, Huang N, B\u00e9cavin C, Berg M, Queen R, Litvinukova M, Talavera-L\u00f3pez C, Maatz H, Reichart D, Sampaziotis F. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"8813_CR43","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1093\/cid\/ciab945","volume":"75","author":"KD Vihta","year":"2022","unstructured":"Vihta KD, Pouwels KB, Peto TE, Pritchard E, Eyre DW, House T, Gethings O, Studley R, Rourke E, Cook D. Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom. Clin Infect Dis. 2022;75(1):e329\u201337.","journal-title":"Clin Infect Dis"},{"key":"8813_CR44","doi-asserted-by":"crossref","unstructured":"Vihta KD, Pouwels KB, Peto TE, Pritchard E, House T, Studley R, Rourke E, Cook D, Diamond I, Crook D, Clifton DA. Omicron-associated changes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) symptoms in the United Kingdom. Clin Infect Dis. 2023;76(3):e133\u201341.","DOI":"10.1101\/2022.01.18.22269082"},{"issue":"6","key":"8813_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11343","volume":"23","author":"C Cojocaru","year":"2022","unstructured":"Cojocaru C, Cojocaru E, Turcanu AM, Zaharia DC. Clinical challenges of SARS-CoV-2 variants. Exp Ther Med. 2022;23(6):1\u20139.","journal-title":"Exp Ther Med"},{"issue":"9","key":"8813_CR46","doi-asserted-by":"publisher","first-page":"e1003777","DOI":"10.1371\/journal.pmed.1003777","volume":"18","author":"J Elliott","year":"2021","unstructured":"Elliott J, Whitaker M, Bodinier B, Eales O, Riley S, Ward H, Cooke G, Darzi A, Chadeau-Hyam M, Elliott P. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS Med. 2021;18(9):e1003777.","journal-title":"PLoS Med"},{"issue":"10","key":"8813_CR47","doi-asserted-by":"publisher","first-page":"e2235844","DOI":"10.1001\/jamanetworkopen.2022.35844","volume":"5","author":"C Marquez","year":"2022","unstructured":"Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, Wang C-Y, Pilarowski G, Ribeiro S, Jones D. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA. 1 Periods. JAMA Network Open. 2022;5(10):e2235844\u2013e2235844.","journal-title":"JAMA Network Open"},{"key":"8813_CR48","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1017\/S0950268822001297","volume":"150","author":"AK Ekroth","year":"2022","unstructured":"Ekroth AK, Patrzylas P, Turner C, Hughes GJ, Anderson C. Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) from routine contact tracing data in England. Epidemiol Infect. 2022;150:e162.","journal-title":"Epidemiol Infect."},{"issue":"5","key":"8813_CR49","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.jinf.2022.02.011","volume":"84","author":"G Lippi","year":"2022","unstructured":"Lippi G, Nocini R, Henry BM. Analysis of online search trends suggests that SARS-CoV-2 Omicron (B. 1.1. 529) variant causes different symptoms. J Infect. 2022;84(5):e76\u20137.","journal-title":"J Infect"},{"issue":"2","key":"8813_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/microorganisms10020451","volume":"10","author":"S Arora","year":"2022","unstructured":"Arora S, Grover V, Saluja P, Algarni YA, Saquib SA, Asif SM, Batra K, Alshahrani MY, Das G, Jain R. Literature review of omicron: a grim reality amidst COVID-19. Microorganisms. 2022;10(2):451.","journal-title":"Microorganisms"},{"key":"8813_CR51","first-page":"368","volume":"2020","author":"X-W Xu","year":"2019","unstructured":"Xu X-W, Wu X-X, Jiang X-G, Xu K-J, Ying L-J, Ma C-L, Li S-B, Wang H-Y, Zhang S, Gao H-N: Clinical findings in a group of patients infected with the,. novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2019;2020:368.","journal-title":"BMJ"},{"issue":"6","key":"8813_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.15585\/mmwr.mm7106e2","volume":"71","author":"ME Modes","year":"2022","unstructured":"Modes ME, Directo MP, Melgar M, Johnson LR, Yang H, Chaudhary P, Bartolini S, Kho N, Noble PW, Isonaka S. Clinical characteristics and outcomes among adults hospitalized with laboratory-confirmed SARS-CoV-2 infection during periods of B. 1.617. 2 (Delta) and B. 1.1. 529 (Omicron) variant predominance\u2014one hospital, California, July 15\u2013September 23, 2021, and December 21, 2021\u2013January 27, 2022. Morb Mortal Wkly Rep. 2022;71(6):217\u201323.","journal-title":"Morb Mortal Wkly Rep."},{"issue":"4","key":"8813_CR53","first-page":"399","volume":"3","author":"SK Ettaboina","year":"2021","unstructured":"Ettaboina SK, Nakkala K, Laddha K. A mini review on SARS-COVID-19\u20132 omicron variant (B. 1.1. 529). Sci Med J. 2021;3(4):399\u2013406.","journal-title":"Sci Med J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08813-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08813-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08813-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T12:04:05Z","timestamp":1701173045000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08813-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8813"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08813-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Ethics Committee of Birjand University of Medical Sciences (Ethics code: Ir.bums.REC.1399.248). Moreover, the informed consent was obtained from all participants. All experiments were performed with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"838"}}